Annual Report 2010 of Beacon Pharmaceuticals Limited

It is a broadly described annual report of Beacon Pharmaceuticals Limited in the year of 2010. During the year, the company registered an impressive 58% sales growth to reach Tk. 554.27 million as compared to Tk. 350.81 million in 2009. The company’s total operating revenue was BDT. 18,92,40,494 in 2010 as against BDT. 10,02,22,382 of 2009. Profit from operation Increased from BDT. 1,83,25,735 to BDT. 141,14.850 representing an increase of 31.59 percent over last year. Tax holiday reserve of BDT. 24,11,485 has been provided in 2010. Earning per share was BDT.0.13 as against BDT. 0.31 of last year. Earning per share decreased from 0.31 to 0.13.

The Board of Directors has not recommended any dividend for the year ended 30th June 2010 because of the amount of profit is not sufficient for distribution to the shareholders. Earning per share Tk.0.13 and retained earnings Tk. 0.22 million as on 30th June 2010. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.

More Annual Report of Beacon Pharmaceuticals Limited:

  1. Annual Report 2010 of Beacon Pharmaceuticals Limited
  2. Annual Report 2012 of Beacon Pharmaceuticals Limited
  3. Annual Report 2013 of Beacon Pharmaceuticals Limited
  4. Annual Report 2014 of Beacon Pharmaceuticals Limited
  5. Annual Report 2015 of Beacon Pharmaceuticals Limited
  6. Annual Report 2016 of Beacon Pharmaceuticals Limited